Inflation Reduction Act

  • The Centers for Medicare & Medicaid Services (CMS) has announced it will proceed with Medicare drug price negotiations under the current administration, emphasizing a commitment to greater transparency in the process. This second round of negotiations will include high-profile, expensive weight-loss drugs like Ozempic and Wegovy. CMS stated that lowering drug prices remains a top…

    Medicare Drug Price Negotiations to Continue, with Focus on Transparency
  • The U.S. Treasury’s release of final rules for hydrogen tax credits under section 45V of the Inflation Reduction Act marks a pivotal moment for the burgeoning hydrogen industry. Long hailed as a critical tool for decarbonizing heavy industry and long-haul transportation, hydrogen production has faced significant challenges, particularly the absence of clear regulatory guidelines. These…

    U.S. Hydrogen Tax Credit: Clarity for Industry, Progress for Sustainability